Survival Outcomes in Patients With Advanced Hepatocellular Carcinoma Treated With Drug-Eluting Bead Chemoembolization is organized by American Roentgen Ray Society (ARRS) and will be held during Jan 23, 2015 - Jan 22, 2021.
The target audience for this medical event is readers of the AJR, radiologists, radiologists-in-training, and other health professionals with an interest in the treatment of hepatocellular carcinoma. This CME Conference has been approved for a maximum of 1.00 AMA PRA Category 1 Credits.
Conference Objectives are :
• Understand the criteria for tumor staging and treatment of hepatocellular carcinoma.
• Understand the treatment options and survival patterns of advanced hepatocellular carcinoma.
Additional details will be posted as soon as they are available.
Vascular and Interventional Radiology, Gastrointestinal Endoscopy, Oncology, Hepatology